NOV 27, 2019 4:40 PM PST

3D-printed cell traps catch cancer cells on the move

WRITTEN BY: Tara Fernandez

The early stages of metastasis, or the spread of cancer cells from the primary tumor site, are incredibly difficult to detect by analyzing blood samples. For a 10 milliliter sample, this would mean positively identifying a mere handful of cancerous cells amidst 50 million blood cells.

A. Fatih Sarioglu and collaborating investigators at the Georgia Institute of Technology are turning to 3D-printing technology for solutions — using cell traps to narrow the analysis pool, making cancer cells considerably easier to spot.

In research published in the journal Lab on a Chip, the team from the School of Electrical and Computer Engineering (ECE) designed devices with intricate layers of microfluidic channels, through which a patient’s blood sample would flow through. The architecture of the fluid path extracts larger cells (such as white blood cells and cancer cells), letting smaller red blood cells continue to flow through. 

Analyzing just the subpopulation of trapped cells makes the cancer diagnostic process significantly simpler, faster and cheaper. The instrument is also designed to be gentle enough to keep any captured tumor cells completely intact — a critical design feature to maximize diagnostic accuracy.

As tumors advance, they can begin to migrate to distant sites in the body by invading into surrounding tissue structures, traveling with the flow of the lymphatic system, or via the blood circulation. Wide-spread tumor metastasis dramatically decreases a patient’s chance of survival, making early warnings potentially life-saving. 

For instance, just over 50 percent of patients with lung cancer are expected to live five years past diagnosis. At later stages of cancer, metastasis causes this rate to drop to just 5 percent.

To evaluate the effectiveness of their new technology, the researchers spiked healthy blood samples with known numbers of cancer cells and ran the samples through the device. Results indicated that the device was highly effective, having snared 90 percent of tumor cells.

The device was also found to be successful in catching circulating cancer cells in small amounts of blood drawn from patients with metastatic prostate cancer.

Future iterations of the device will focus on further simplifying its design and boosting its performance and manufacturability. 

It is anticipated that commercializing this technology would be a big step up for the future of personalized medicine by allowing clinicians to detect red flags and execute treatment strategies against metastatic cancer earlier and more effectively.

 

Sources: Science Daily, Futurity, Lab on a Chip

Photo credit: Allison Carter, Georgia Tech

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 14, 2020
Genetics & Genomics
Denisovan DNA Influences the Immune System of Oceanian People
JUN 14, 2020
Denisovan DNA Influences the Immune System of Oceanian People
As species in the genus homo evolved, our ancient ancestors interbred with populations of Neanderthals and Denisovans.
JUN 24, 2020
Microbiology
Genetic Variations Can Affect the Gut Microbiome
JUN 24, 2020
Genetic Variations Can Affect the Gut Microbiome
The small variations in the human genome aren't the only thing that make us unique. We also each carry communities of mi ...
JUL 03, 2020
Cancer
Using Machine Learning to Further Classify Triple-Negative Breast Cancer
JUL 03, 2020
Using Machine Learning to Further Classify Triple-Negative Breast Cancer
One of the challenges of facing cancer researchers is coming up with a clearly defined classification system. Cancer is ...
JUL 07, 2020
Clinical & Molecular DX
Throat Swabs Prevent COVID False Negatives
JUL 07, 2020
Throat Swabs Prevent COVID False Negatives
  False-negative results are particularly problematic in containing the spread of COVID-19 — infected individ ...
JUL 09, 2020
Immunology
Infection During Pregnancy Could Trigger Autism in Children
JUL 09, 2020
Infection During Pregnancy Could Trigger Autism in Children
Researchers from the Center for Neuroscience at the University of California, Davis have revealed new insights into the ...
JUL 12, 2020
Cell & Molecular Biology
Lung Cancer is Different in Non-Smokers
JUL 12, 2020
Lung Cancer is Different in Non-Smokers
Not everyone that gets lung cancer is a current or former smoker, and researchers have now found that lung cancer is dif ...
Loading Comments...